CLDN6 and ovarian cancer: Collectively, these results demonstrated that CLDN6-CAR1 NK cells could suppress ovarian cancer progression in the s.c. mouse models and the peritumoral delivery approach significantly enhanced CAR-NK cell infiltration into solid tumors compared with intravenous delivery.